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Abstract Ligands interacting with Mycobacterium tuber-
culosis recombinant proteins were identiﬁed through use of
the ability of Cibacron Blue F3GA dye to interact with
nucleoside/nucleotide binding proteins, and the effects of
these ligands on crystallization were examined. Co-crystal-
lization with ligands enhanced crystallization and enabled
X-ray diffraction data to be collected to a resolution of at
least 2.7 A ˚ for 5 of 10 proteins tested. Additionally, clues
about individual proteins’ functions were obtained from
their interactions with each of a panel of ligands.
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Abbreviations
ADP Adenosine-50-diphosphate
AMP Adenosine-50-monophosphate
ATP Adenosine-50-triphosphate
DNA Deoxyribonucleic acid
DTT Dithiothreitol
FAD Flavin-adenine dinucleotide
GTP Guanosine-50-triphosphate
IPTG Isopropyl-b-D-thiogalactoside
NAD Nicotinamide adenine dinucleotide
NADH Nicotinamide adenine dinucleotide hydride
NADP Nicotinamide adenine dinucleotide phosphate
NADPH Nicotinamide adenine dinucleotide phosphate
hydride
OD Optical density
PCR Polymerase chain reaction
PMSF Phenylmethylsulfonyl ﬂuoride
SDS-PAGE Sodium dodecyl sulfate polyacrylamide gel
electrophoresis
UTP Uridine-50-triphosphate
Introduction
Obtaining diffraction-quality crystals is a major bottleneck
in determining macromolecular structures using X-ray
crystallography [1, 2]. Various general approaches have
been suggested for improving crystallization, including
systematic screening of conditions [3]; seeding with small
crystals [4]; cell-free expression [5]; screening multiple
starting and ending amino acid positions for expression
clones [6]; identifying domains by partial proteolysis [7, 8];
crystallizing complexes of small proteins [9, 10]; per-
forming surface engineering [11]; using crystallization
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ligands to increase crystallization [13] (See recent review
of [14].
Ligand supplementation is particularly attractive as an
option for improving crystallization in cases where ligand
information for the target protein can be predicted from
sequence-based functional annotation [15, 16]. If the right
ligand is chosen, the effect on crystallization can be dra-
matic [17, 18]. In practice, the success rate of this approach
is limited by the accuracy of ligand prediction for target
proteins. In many cases, available annotations give little or
no useful information on the ligand for target proteins.
Estimates of error rates in annotation of gene function
range from 5% to over 80% depending on the annotation
methods and the database [19, 20], and this can lead to an
incorrect choice of ligands. The unknown and hypothetical
proteins that account for 25–60% of genome sequences
give no indications of ligand [21–23]. As crystallization
can be enhanced by addition of correctly selected ligand(s),
accurate ligand information would be of substantial utility
in crystallization.
After the fortuitous discovery of the binding of Cibacron
Blue F3GA to enzymes led to the concept of using dyes for
afﬁnity chromatography [24], several triazine dyes were
applied to enzyme puriﬁcation as afﬁnity resins. One of the
most popular triazine dyes, Cibacron Blue F3GA, was
found to interact with a variety of enzymes such as NAD-
and NADP-dependent dehydrogenases, kinases, glucose
oxidase, lysozyme, albumin, catalase, ovalbumin, as well
as plasma proteins [25–31].
We have made use of the interaction of Cibacron Blue
F3GA dye with nucleoside and nucleotide binding proteins
to identify protein–ligand interactions [32]. Taking
advantage of the binding of Cibacron Blue F3GA dye to a
variety of cellular enzymes, we expanded the use of this
dye from protein puriﬁcation to high-throughput ligand
identiﬁcation of resin-bound proteins by selective elution
with ligands [17, 32]. The premise of our approach is that a
ligand that interacts speciﬁcally with a protein can release
that protein from the dye-resin competitively. Crude cell
extracts are applied to the dye-resin and the proteins eluted
by each of a series of potential ligands are identiﬁed by
two-dimensional electrophoresis and mass spectrometry
[32]. Then the speciﬁcity of interactions is further tested by
examining the elution of puriﬁed recombinant proteins
from the dye-resin by individual ligands [17].
In this report, we demonstrate the general application of
the F3GA dye-ligand afﬁnity chromatography method to
enhancing crystallization of 9 recombinant proteins chosen
from a set of 26 Mycobacterium tuberculosis (Mtb) targets
that we previously found to interact with nucleoside/
nucleotide ligands [32].
Materials and methods
Target selection, expression and puriﬁcation of proteins
From our previous study with Mtb strain H37Rv cell
extract in which we identiﬁed proteins interacting with
nucleotide-ligands [32], 26 genes were selected and used in
cloning. All genes in this study were ampliﬁed by PCR
from a Mtb H37Rv genomic DNA, using Pfu polymerase
(Stratagene), and the following primers: 50-TACTTCC
AATCCAATGCGAT G ? N-terminal 20 nucleic acids
coding region of target protein-30 (forward) and 50-TTA
TCCACTTCC AATGTTA ? C-terminal 20 nucleic acids
coding region of target protein-30 (reverse). The underlined
bases were to generate ligation-independent cloning (LIC)
sites for the pMCSG7 vector [33]. The pMCSG7 vector
was digested with the SspI restriction enzyme (Promega),
and the ampliﬁed and puriﬁed PCR product and a singly
digested pMCSG7 vector were treated with T4 DNA
polymerase (Novagen). The 50 llo fEscherichia coli
NovaBlue cells (Novagen) was transformed with the self-
annealed PCR product and pMCSG7 vector. The insert of
genes in plasmids was conﬁrmed by DNA sequencing.
E. coli BL21(DE3) cells were used to express the
cloned genes. Cells were grown at 37Ci nL Bm e d i u m
(Sigma) containing 100 lg/ml ampicillin, induced with
1 mM IPTG when OD600 reached 1.0, and grown at
25C overnight in a shaking incubator set at 250 rpm.
The cells were harvested and stored at -80C. The
expression of each protein was checked by SDS-PAGE
[34].
For puriﬁcation of expressed proteins, frozen cells
were thawed on ice and resus p e n d e di nl y s i sb u f f e r
(20 mM Tris–HCl pH 8.0, 200 mM NaCl, 1 mM PMSF,
1 mg/ml DNase, 1 mM MgCl2). Lysates were sonicated
and then centrifuged with 3,000 g at 4C for 30 min.
The supernatant was ﬁltered through a 0.45 lmp o r e
membrane (Stericup, Millipore) and loaded on a Ni–
NTA superﬂow afﬁnity column (Qiagen). After being
washed with buffer A (20 mM Tris–HCl pH 8.0,
200 mM NaCl), the target protein was eluted by buffer
B (buffer A plus 500 mM imidazole). To remove the
contaminants, eluted fractions were further puriﬁed on a
Superdex-75 gel ﬁltration column (GE Healthcare Inc.)
using buffer C (10 mM Tris–HCl pH 8.0, 150 mM
NaCl, and 1 mM DTT). A centrifugal concentrator
(Millipore) was used to concentrate the pooled protein
fractions to 5–15 mg/ml, as measured by Bradford
reagent (Bio-Rad). Protein purity was conﬁrmed by
SDS-PAGE and densitometry. A summary of progress
from solubility test to X-ray data collection is included
in Supplementary Table 1.
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chromatography
To evaluate recombinant proteins for their speciﬁc ligand-
binding properties, we followed a modiﬁed version of the
protocol described by Kim et al. [17]. Brieﬂy, individual
puriﬁed proteins were diluted to 1–2 mg/ml in column
buffer (CB; 50 mM potassium phosphate, pH 7.5, 1 mM
MgCl2 and 2 mM DTT), and 100 lg protein was adsorbed
to multiple 50 ll aliquots of F3GA resin (Bio-RAD) in
2 ml spin-columns (Costar, Fisher Scientiﬁc). Aliquots
(F3GA resin ? proteins) were vortexed for 1 h at 4C for
binding, followed by recovery of unbound protein (ﬂow-
through fraction) and washing of the resin (4 9 0.4 ml
washes with CB); spin-columns were centrifuged for 30 s
at 10,000 g to recover fractions and change solutions.
Individual spin-columns containing resin-bound proteins
were then incubated (as for protein binding) with 50 ll,
1 mM ligand in CB, and the eluate fraction was recovered
by centrifugation. The ligands used in this experiment were
NAD, NADH, NADP, NADPH, AMP, ADP, ATP, and
GTP (FAD was used additionally for the conserved hypo-
thetical protein). Aliquots of initial protein, ﬂow-through,
and eluate fractions were diluted with 1:1 volume ratio
with 2 9 SDS sample buffer, and 15 ll was loaded in
equal proportion (equivalent to 1 lg input protein) on 10%
SDS-PAGE. For quantitative evaluation of the interaction
of each ligand with protein, stained gel-bands were scanned
by densitometry (GS-800, Bio-RAD). We calculated a
‘‘densitometric trace’’ of each gel-band by integration of
the absorbance of the stained band using the software,
Quantity One 4.3.1. Each protein’s resin-bound portion
was calculated by subtracting the portion of ﬂow-through
from the loaded protein. The protein portion eluted by each
ligand was calculated as a percentage of the resin-bound
protein. (Table 1 and Supplementary Table 2). We tested
33 of the 72 ligand–protein interactions examined in this
work three times to estimate the uncertainty in our mea-
surements of percentage bound to the dye column. The
range of the percentage bound was less than ±15% from
the mean in each case, and averaged *10%.
Crystallization and X-ray data collection of proteins
without and with ligands
Proteins were crystallized without and with ligand(s) that
had been identiﬁed with our dye-ligand interaction
approach. For initial screening, hanging drops (1 ll pro-
tein–ligand solution ? 1 ll reservoir solution) were set up
in 24-well plates using crystal screen 1 and 2 (Hampton
Research). To compare the effect of ligand(s) on crystal-
lization under identical conditions, two or more drops that
include one drop without ligand and other drop(s) with
ligand(s) were set up on a cover-slip of each well
depending on the number of identiﬁed ligands for each
protein by dye-ligand afﬁnity chromatography. If crystals
were observed in multiple wells, we chose the well of best
crystal based on size and morphology and optimized its
crystallization condition, if possible, by ﬁne-tuning each
component until crystals with dimensions of at least
50 lm 9 50 lm 9 50 lm were obtained. For co-crystal-
lization with ligand, each protein (0.2–0.5 mM in buffer C)
was mixed with the identiﬁed ligand at a molar ratio of
protein: ligand, 1:2.5 (and 1:5 to see the effect of
enhancement of crystallization with more ligand, but no
clear difference in enhancement of crystallization was
Table 1 Estimation of retention of recombinant Mtb proteins on Cibacron Blue F3GA resin shown in Fig. 1
Proteins Resin-bound portion of
loaded protein (%)
a
Eluted portion of bound protein (%)
b
NAD NADH NADP NADPH AMP ADP ATP GTP
NAD(P) transhydrogenase 100 0 24 0 0 0 0 0 0
Short-chain-type dehydrogenase/reductase 100 0 0 74 99 0 0 0 0
Short-chain-type oxidoreductase 100 0 0 0 15 0 0 0 0
6-phosphogluconate dehydrogenase 66 0 31 0 2 0 1 0 0
Secreted L-alanine dehydrogenase 100 0 55 0 0 0 0 11 0
Methylmalonate-semialdehyde
dehydrogenase
63 0 13 0 5 8 0 0 0
5-methyltetra-hydropteroyltriglutamate-
homocysteine methyltransferase
86 5 11 3 29 17 9 17 42
3-hydroxy-isobutyrate dehydrogenase 100 40 74 0 15 26 26 41 26
a The resin-bound portion of protein was estimated as a percentage of the total protein loaded by subtracting the ﬂow-through portion from the
loaded amount. Amounts of protein loaded and obtained in the ﬂow-through were estimated from densitometry of stained SDS gels as in Fig. 1,
as detailed in Supplementary Table 2
b The eluted portion of bound protein was calculated by dividing the amount of protein eluted with each ligand by the amount of resin bound
protein
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123observed depending on ligand concentration), and incu-
bated on ice for 30 min prior to set-up crystallization. For
X-ray data collection, a minimum of ﬁve protein crystals
grown were selected based on size and morphology, har-
vested and ﬂash-cooled in liquid N2, with the addition of
10–20% glycerol in the buffer as cryoprotectant.
Monochromatic datasets were collected at the beam
lines 5.0.1 and 5.0.2 at the Advanced Light Source (ALS).
The wavelengths used for each data collection and the
estimated standard deviations (esd’s) of the wavelengths
are listed in Table 2. All datasets were processed with the
HKL2000 program suite [35]. Detailed data collection
statics are listed in Table 2.
Results and discussion
Protein preparation and nucleotide ligand analysis
by dye-ligand afﬁnity chromatography
To determine whether the ligand(s) identiﬁed by F3GA
dye-ligand afﬁnity chromatography method can enhance
crystallization, we selected 26 proteins from Mtb cell
extracts for which the approach identiﬁed potential ligand
interactions [32]. All 26 target genes were successfully
cloned, and expression of each was conﬁrmed. Solubility
tests indicated that 10 of these were insoluble when
expressed in E. coli, and these were not considered further.
Crystal structures of three of the remaining 16 soluble
proteins were already present in the Protein Data Bank
(PDB, [36]; PDB codes listed in Supplementary Table 1)
and these proteins were also not considered further. We
puriﬁed the remaining 13 proteins.
The ﬁrst step in our dye-ligand afﬁnity chromatography
experiment is normally evaluation of protein adsorption
onto the Cibacron Blue F3GA dye resin. The buffer used in
these experiments contains phosphate (50 mM), which we
note might possibly compete weakly with dye binding and
decrease weak or non-speciﬁc interaction of protein with
dye resin. All proteins in this report had previously shown
interactions with the F3GA resin, and binding to the resin
was conﬁrmed for all proteins (data not shown). For three
of the 13 proteins, the ligand-speciﬁc elution analysis
described below did not show interactions with the ligands
we tested. These three (3-hydroxybutyryl-CoA dehydro-
genase, probable fatty acid oxidation protein, and trypto-
phanyl-tRNA synthetase) were not considered further.
Crystallization trials without and with ligand(s) identiﬁed
in this analysis were set up for the remaining 10 proteins
(Supplementary Table 1). Eight of these ten proteins (all
but NAD(P) transhydrogenase and short-chain-type oxi-
doreductase) had previously been targeted by members of
Table 2 Statistics on X-ray data collection of four proteins, for which ligands information improved crystallization
Data collection NAD(P) trans-
hydrogenase
Short-chain-type dehydrogenase/
reductase
6-phosphogluconate
dehydrogenase
Secreted L-alanine dehydrogenase
NADH NADP NADPH NADH NADH ATP
Space group P21 P21212P 2 1212 P4212 R32 R32
Unit cell parameters (esd’s)
a 65.144 (0.001) 160.450 (0.001) 159.395 (0.001) 108.280 (0.001) 88.154 (0.001) 89.047 (0.001)
b 151.841 (0.001) 159.952 (0.001) 160.801 (0.001) 108.280 (0.001) 88.154 (0.001) 89.047 (0.001)
c( A ˚) 76.306 (0.001) 86.189 (0.001) 172.583 (0.001) 144.938 (0.002) 291.390 (0.003) 290.981 (0.004)
a, b, c (degree) a = c = 90,
b = 114.38
(0.001)
a = b = c = 90 a = b = c = 90 a = b = c = 90 a = b = 90,
c = 120
a = b = 90,
c = 120
Resolution limits
a
(A ˚)
50.00–2.28
(2.32–2.28)
50.00–2.00
(2.03–2.00)
50.00–2.00
(2.03–2.00)
50.00–2.70
(2.75–2.70)
50.00–2.00
(2.03–2.00)
50.00–2.40
(2.43–2.40)
Wavelength (A ˚) 0.9774 1.0000 0.9202 1.0000 1.0000 1.0000
No. of Unique
Reﬂections
59,257 148,901 298,159 24,403 29,900 17,977
No. of Total
Reﬂections
209,793 1,088,722 2,214,370 167,780 177,183 106,091
Rmerge
b (%) 6.4 (28.0) 10.6 (93.7) 9.5 (63.3) 15.9 (78.5) 5.7 (58.9) 6.5 (34.9)
Completeness (%) 96.6 (85.0) 98.7 (97.9) 100.0 (100) 100.0 (99.7) 100.0 (99.9) 99.6 (99.4)
\I/r(I)[ 13.1 (3.6) 9.3 (2.0) 8.5 (2.8) 5.8 (2.0) 16.4 (2.6) 16.6 (4.4)
Redundancy 3.5 (3.0) 7.3 (6.4) 7.4 (7.4) 6.9 (6.2) 5.9 (5.6) 5.9 (5.8)
a Numbers in parentheses refer to the highest resolution shells
b Rmerge = RjIobs - Iavgj/RIavg
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for crystallization and structure determination, but various
attempts to solve structures had failed (http://www.webtb.
org).
The enhancement of crystallization for one of these
proteins (aldehyde dehydrogenase) with nucleoside ligands
has been reported previously [17], and the experimental
data for the remaining nine proteins are presented here. For
all but one of these (the conserved hypothetical protein)
addition of ligands improved crystallization (Supplemen-
tary Table 1). The eight proteins for which ligand addition
improved crystallization are examined in more detail
below. Figure 1 shows the application of the dye-ligand
afﬁnity chromatography approach to these eight Mtb pro-
teins, testing interactions with eight common nucleotide
ligands. The basis of this experiment is that the binding of
ligand affects the binding of the protein to the resin. Initial
binding of each protein to the resin was conﬁrmed by the
small relative amount in the ﬂow-through fraction (lane 2)
compared with the amount loaded (lane 1). For ﬁve of eight
proteins, essentially all of the applied protein was bound to
the resin. For the three others (6-phosphogluconate dehy-
drogenase, methylmalonate-semialdehyde dehydrogenase,
and 5-methyltetra-hydropteroyl triglutamate-homocysteine
methyl-transferase), unbound protein accounted for
14–37% of the loaded protein amount, respectively
(Table 1). Ligands interacting with each of the eight pro-
teins were identiﬁed by selective elution of the proteins. A
relative measure of the interaction of each ligand with each
protein could be obtained from the fraction of resin-bound
protein that is eluted by that ligand (see ‘‘Materials and
methods’’ and Supplementary Table 2), and is presented in
Table 1.
Of eight proteins shown in Fig. 1, ﬁve revealed very
obvious interactions with ligands. The proteins annotated
as NAD(P) transhydrogenase, short-chain-type oxidore-
ductase, 6-phosphogluconate dehydrogenase, and secreted
L-alanine dehydrogenase showed elution dominated by one
ligand (NADH or NADPH). The short-chain-type dehy-
drogenase/reductase was eluted with two ligands (NADP
and NADPH). In the case of methylmalonate-semialdehyde
dehydrogenase, three ligands showed interactions. In con-
trast, the proteins annotated as 5-methyltetra-hydropteroyl
triglutamate-homocysteine methyltransferase and 3-hydroxy-
isobutyrate dehydrogenase interacted with most of the ligands
tested. Additionally, the conserved hypothetical protein
showed interaction with FAD (Supplementary Tables 1 and
2).
Based on existing annotations, the eight proteins shown
in Fig. 1 are likely all to be dehydrogenases or reductases,
and they would be expected to interact with either NAD/
NADH or NADP/NADPH. The ligand interactions indi-
cated by our dye-elution analysis give clues as to the likely
cofactors for several of these proteins. As NAD(P) transhy-
drogenase, 6-phosphogluconate dehydrogenase, and secre-
ted L-alanine dehydrogenase are eluted most readily with
NADH, we suggest that they may be NAD/NADH-depen-
dent dehydrogenases. In contrast, short-chain-type dehy-
drogenase/reductase and short-chain-type oxidoreductase
are eluted speciﬁcally by NADP and/or NADPH, and
therefore may be NADP/NADPH-dependent enzymes. The
proteins NAD(P) transhydrogenase, 6-phospho gluconate
Fig. 1 Nucleotide ligand
interaction assay using Mtb
recombinant proteins by dye-
ligand afﬁnity chromatography.
The dye-ligand afﬁnity
chromatography results from
SDS-PAGE show binding of
eight target proteins to Cibacron
Blue F3GA and subsequent
selective elution in response to
exposure to a sequence of eight
different nucleotide ligands
(NAD, NADH, NADP,
NADPH, AMP, ADP, ATP, and
GTP)
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123dehydrogenase, secreted L-alanine dehydrogenase, and
short-chain-type oxidoreductase showed preferred interac-
tions with the reduced form of cofactors (NADH or
NADPH), suggesting that these enzymes may be involved
in a reduction process.
During our work, structural and interaction data for
secreted Mtb L-alanine dehydrogenase with NADH and
other ligands was reported by Agren et al [37]. In
agreement with our ligand interaction data, a strong
interaction of this protein with NADH was conﬁrmed
(Kd = 8.2 lM and Km = 10.7 lM) showing that this
enzyme is likely to be involved more in reductive ami-
nation converting pyruvate and ammonia to L-alanine
rather than reverse oxidative deamination. These obser-
vations were also supported by kinetic parameters of this
enzyme: Kcat = 694 ± 33/s, Km,pyruvate = 0.76 ± 0.05
mM for reductive amination versus Kcat = 126 ± 4/s,
Km,L-alanine = 15.64 ± 1.09 mM for oxidative deamina-
tion. This agreement with our observations suggests that
protein–ligand interaction proﬁles obtained by dye-ligand
afﬁnity chromatography can produce not only information
about ligand binding to a protein, but also useful func-
tional information.
Ligand(s) of a protein can be predicted from sequence-
based annotation and from homologous protein’s structure
solved with ligand. The challenges of ligand prediction by
sequence-based annotation were mentioned above. Since
all eight proteins used in this experiment are annotated in
the category of dehydrogenases or reductases, we can
predict all four nicotinamide nucleotides (NAD, NADH,
NADP and NADPH) and can further suggest many
nucleotides and nucleosides that are related to these as
potential ligands, but it is hard to tell which one actually
interacts with protein or improves crystallization until we
screen each protein’s crystallization conditions with all of
them. Similarly, when all the ligands bound to structures of
proteins in the PDB with 30% or higher amino acid
sequence identity for each of ﬁrst ﬁve proteins in Fig. 1 are
listed, many potential ligands are predicted for each pro-
tein. In contrast, ligands that showed clear interaction with
protein by our method often enhanced crystallization as
shown in Fig. 2, allowing us to make progress up to X-ray
data collection as shown in Table 2.
Inhibition studies of several enzymes such as phos-
phoglycerate kinase, phospho-glycerate mutase, cyclic
30,50-monophosphate dependent protein kinase, myosin
Fig. 2 Ligand-enhanced
crystallization of Mtb
recombinant proteins. Proteins
were crystallized in the absence
(Native, left) or presence (right)
of various nucleotide ligands, as
indicated. Ligand selection was
based on the results of the
ligand interaction assay (Fig. 1
and Table 1). Enhanced
crystallization of protein–ligand
co–crystals, relative to native
protein alone, was observed for
all eight proteins, and allowed
for structural resolution of four
proteins (resolution of the
collected diffraction data is
indicated in parentheses)
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123subfragment 1, chloroplast coupling factor 1 using Ciba-
cron Blue F3GA dye indicate that the dye inhibits enzyme
activities by pre-occupation of the ligand binding site
[38–41]. In the dye-ligand afﬁnity chromatography
approach, with the assumption that protein elution occurs
by replacement of dye with nucleotide ligand at nucleotide
binding sites, we may be able to design and test inactive
enzyme variants by mutation of residues that are critical
for ligand interaction once the enzyme-ligand interaction
mode is elucidated by solving the enzyme structure bound
to the ligand.
Enhancement of crystallization by the ligands identiﬁed
with dye-ligand elution
To examine the effects on crystallization of ligand(s) iden-
tiﬁed with our methods, nine Mtb proteins were crystallized
without and with corresponding ligand(s) (Supplementary
Table 1). Crystallization of six native proteins (without
ligand) revealed no crystals in any condition and two (6-
phosphogluconate dehydrogenase and secreted L-alanine
dehydrogenase) generated relatively small crystals com-
pared to proteins set up with ligands. In contrast, the co-
crystallization of eight proteins (all but the conserved
hypothetical protein) with ligands enhanced crystallization
in various ways that we have never achieved with the native
proteins (Fig. 2). Given the negative or poor crystallization
results of native proteins relative to the results of protein
with ligand(s) under identical crystallization conditions, we
did not further pursue crystallization with native proteins
by further screening of crystallization conditions or by
protein modiﬁcation. We categorize the enhancements by
ligands in three groups: immediate formation of large new
crystals (group 1), increases in crystal size (group 2), and
the initiation of new crystals of small size (group 3). We
found that of the proteins in group 1, NAD(P) transhydro-
genase and short-chain-type dehydrogenase/reductase
yielded new crystals diffracting to resolutions of 2.0–2.3 A ˚,
whereas the crystals of short-chain-type oxidoreductase
with NADPH diffracted but did not generate useful dif-
fraction data and might need intensive screening of cryo-
conditions. Of the proteins in group 2, larger crystals were
obtained from 6-phosphogluconate dehydrogenase in the
presence of NADH, yielding diffraction data to 2.7 A ˚ res-
olution, and the crystals from secreted L-alanine dehydro-
genase with NADH and ATP gave diffraction data to 2.0
A ˚ and 2.4 A ˚ resolution, respectively. When more than one
ligand is identiﬁed, it may be useful to try tight-binding
ligands ﬁrst because they may yield better diffracting
crystals [17]. The group 3 proteins methylmalonate-
semialdehyde dehydrogenase, 5-methyltetra-hydropteroyl
triglutamate-homocysteine methyltransferase, and 3-hydroxy-
isobutyrate dehydrogenase yielded protein crystals with the
ligands (NADH and NADPH, ATP and GTP, and NADH,
respectively) that were conﬁrmed by polarization and staining
withdye,althoughthoseweretoofragileortoosmall(5–10 lm
in the largest dimensions) to harvest (the native proteins gave
mere precipitation and no trace of crystals).
Conclusion
We have demonstrated here the applicability of a novel
method, dye-ligand afﬁnity chromatography, to ligand
screening of nine recombinant Mtb proteins.
A unique feature of this dye-ligand afﬁnity chromatog-
raphy procedure is the generation of information about
ligand interactions, depending on each ligand’s ability to
replace dye at the binding site of protein (Fig. 1).
Depending on the character of the Cibacron Blue F3GA
dye-protein interaction, the ligand-interaction proﬁle
obtained for a given protein can give clues to the protein’s
function.
The advantages of this method over other ligand
analyses, such as the thermal shift assay with ligands [13]
and the ligand chips [42] are that (a) no protein modiﬁ-
cation is required, (b) no special instruments and skill are
required, and (c) the potential for direct monitoring of
ligand interaction by displacement of the dye from the
binding site of the protein. These advantages may allow
the development of a high-throughput ligand analysis
system that can be operated in a cost- and time-effective
manner.
In this report, the ligand(s) identiﬁed by this method
demonstrated a 50% success rate (5 of 10 tested proteins,
including aldehyde dehydrogenase, reported previously by
Kim et al. [17]) for obtaining diffraction data by crystal-
lization improvement. The structure of each protein for
which we have collected data has been solved and is in the
process of reﬁnement (these structures will be reported
elsewhere).
According to earlier reports about the proteins inter-
acting with Cibacron Blue F3GA dye [25–31], most
nucleoside/nucleotide-interacting proteins, or about half of
all enzymes [43], can be candidates for ligand analysis
using the dye-ligand afﬁnity chromatography method.
Based on our data, the method seems especially efﬁcient
for identifying ligand(s) if the target protein is annotated as
an NAD/NADH-binding (and NADP/NADPH-binding)
protein.
We suggest that a useful structural genomics approach
will be to use our methods to identify ligands for target
proteins early in the process and then to co-crystallize
target proteins with the identiﬁed ligand(s), potentially
yielding functional insights and improving crystal forma-
tion and diffraction data.
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